Christine Seidman

Dr. Christine E. Seidman is the Director of the Cardiovascular Genetics Program at Brigham and Women’s Hospital and the Thomas W. Smith Professor of Medicine at Harvard Medical School. She is also an Investigator of the Howard Hughes Medical Institute. While many scientists master either basic research or clinical practice, Seidman has blazed a trail in cardiovascular science with her unique approach to research focused on elucidating the genetic causes for heart disease and other disorders. Among her many notable achievements is the discovery of the first genetic cause of congenital heart malformations. More recently, Seidman used a gene-sequencing technique called PMAGE to identify hundreds of early-acting genes that could be responsible for hypertrophic cardiomyopathy. As both a clinician and researcher, Seidman promotes collaboration between her lab and the Brigham and Women’s Hospital Cardiovascular Genetics Center to translate research discoveries into better diagnostics and improved management strategies. Seidman has received numerous accolades for her research including the Schottenstein Prize in Cardiovascular Science, the Grand Prix Lefoulon-Delalande, the Bristol-Myers Squibb Award, the American Heart Association’s Basic Science Prize, and the American Society for Clinical Investigation Award. In addition to her American Academy of Arts and Sciences membership, Seidman is a member of the National Academy of Sciences, the National Academy of Medicine, and the American Heart Association Distinguished Scientists. Her over 300 peer-reviewed articles appear in top tier journals such as Cell, Circulation, and Science.